Delcath Systems to present Phase 2 breast cancer trial at ESMO 2026
DCTH•Delcath Systems will present updates on Phase 2 breast and colorectal cancer trials at the ESMO Congress in Madrid on October 24, 2026. No results from the breast cancer study were disclosed.
1. ESMO presentations
Delcath Systems will present updates on Phase 2 breast and colorectal cancer trials at the ESMO Congress in Madrid on October 24, 2026. The breast cancer study compares melphalan hepatic delivery followed by standard therapy with standard therapy alone; no results were disclosed.
